Clinical trial results presented for the first time today at the Union World Conference on Lung Health revealed evidence to support the use of four new, improved regimens to treat multi-drug resistant tuberculosis or rifampicin-resistant tuberculosis (MDR/RR-TB). The team—led by Médecins Sans...
While COVID-19 raised awareness of the risks of airborne disease in the general population, vulnerable populations - such as the urban poor - were exposed to an increased risk of tuberculosis (TB) infection. Prolonged lockdowns and disruptions to TB services in the Philippines meant those in...
Médecins Sans Frontières/Doctors Without Borders (MSF) called on governments and donors on March 22 to speed up access to new, shorter, safer and more effective treatments* for drug-resistant tuberculosis (DR-TB), as well as the diagnostic tests needed to implement the new treatment regimens. MSF...
Médecins Sans Frontières/Doctors Without Borders (MSF) are pleased that, having shared the results of TB-PRACTECAL, our clinical trial that found a new, safer and more effective six-month oral treatment regimen for multi drug-resistant tuberculosis (MDR-TB), the World Health Organization (WHO) have...
MSF teams remain in Ukraine, and we are currently seeking ways to adapt our response as the conflict situation evolves. We are deeply worried about the consequences of the conflict for Ukrainian people and communities. We see on the roads that tens of thousands of people are frightened and on the...
New results show a much shorter treatment regimen for drug-resistant TB is superior to current care TB-PRACTECAL, a clinical trial led by Médecins Sans Frontières/Doctors Without Borders (MSF) has found that a new all-oral six-month treatment regimen is safer and more effective at treating...
The violence in Afghanistan has surged since May with fighting around and inside provincial capitals between the Afghan forces and the Islamic Emirate of Afghanistan (IEA, also known as the Taliban). This is impeding access to medical care, increasing the number of people killed and wounded by...
After a week of unrest in the KwaZulu-Natal and Gauteng provinces, in South Africa, people are still feeling the effects of the violence, with many vulnerable communities – particularly informal settlements – reporting difficulties in accessing food and health care. Despite calm returning, health...
A trial aiming to find a better treatment for multidrug-resistant tuberculosis (MDR-TB) has stopped enrolling patients early after its independent data safety and monitoring board indicated that the regimen being studied is superior to current care, and more patient data was extremely unlikely to...
The pharmaceutical corporation Johnson & Johnson (J&J) today announced a reduced price of US$1.50* per day for the tuberculosis (TB) drug bedaquiline, which is an important step that should allow more people with drug-resistant forms of TB (DR-TB) to access this lifesaving drug. But the...
